Q2 FY27 results analysis · November 07, 2026
Tata Steel Ltd (TATASTEEL) Q2 FY27 Results Analysis: Revenue Grows 11.5%, Auditors Flag TSN Impairment
+16.2%PAT year on year, Rs. 3,699.59 Cr
Source: Quarterly results filing (NSE)
Quick summary
Tata Steel Ltd's Q2 FY27 numbers came in mixed, with revenue of Rs. 65,436.24 Cr (+11.50% YoY) and PAT growth of +16.20% YoY. Here's a quick read of what worked, what to watch, and what management said.
Quick Details
| Results date | November 07, 2026 |
|---|---|
| Revenue (Q2) | Rs. 65,436.24 Cr (+11.50% YoY) |
| PAT (Q2) | Rs. 3,699.59 Cr (+16.20% YoY) |
| EBITDA margin | 16.30% (+78 bps YoY) |
| EPS (Q2) | Rs. 2.94 (+18.10% YoY) |
Quarter Snapshot
Consolidated revenue grew 11.5% YoY with EBITDA margin at a five-quarter high of 16.30%, and India EBITDA of Rs.10,633.77 crore met management's guided improvement over Q1's Rs.9,908 crore. However, the UK loss widened to Rs.719.25 crore against guidance of losses approaching zero, normalized PAT is down 1.1% YoY, and auditors qualified the standalone accounts over unrecognised TSN impairment indicators of Rs.38,692.59 crore. The pivotal catalyst is TSN clarity expected around the March 1, 2027 JLOI maturity.
Q2 FY27 Expectations vs Results
| Driver | Expected before results | What happened | Verdict |
|---|---|---|---|
| India volumes/realisations ahead; realisations better than the −Rs.1,500/t guide | "volumes should be ahead QoQ"; HRC rally to four-year highs | India revenue +15.3% QoQ, EBITDA +7.3% QoQ; margin compressed as guided | Played out |
| Margin compression on coking coal | "compressing… partially offset by pass-through" | Group margin UP QoQ (15.41→16.30%); India margin DOWN (25.50→24.25%) | Partially |
| West Asia taper claim at risk | "escalated through Jul–Sep" | Q2 quantum undisclosed in filing | Not observable |
| UK losses closer to zero (−£27 mn base) | "on track, with leakage to verify" | −Rs.719.25 cr, widened QoQ | Contradicted |
| Netherlands +€10/t; DSP addressed | "in-line at best, event risk unresolved" | NL result Rs.790.29 cr (recovered); DSP restart not disclosed; JLOI extended to Mar 1, 2027 per the filing — EBITDA); DSP open | Played out |
| Inventory cushion vs cost squeeze | "can partly land as inventory gain" | Changes in inventories −Rs.1,757.41 cr (build) vs drawdown a year ago | Played out |
Read our full results preview.
Management Guidance vs Delivery
| What management said | Where | What happened | Verdict |
|---|---|---|---|
| India EBITDA better in 2Q than Q1's Rs.9,908 cr, despite margin compression | Q1 FY27 earnings call (July 2026) | Rs.10,633.77 cr (India + NINL proxy); margin compressed 25.50%→24.25% | Met |
| UK EBITDA losses shrinking "closer and closer to zero" across 1Q–2Q FY27 | Q4 FY26 earnings call, reiterated Q1 FY27 | −Rs.719.25 cr, ~2.1x worse than Q1's −Rs.340.72 cr | Missed |
| Netherlands +€10/t realisations; DSP issue "addressed" in Q2 | Q1 FY27 earnings call | NL segment result Rs.790.29 cr (vs Rs.39.12 cr); DSP restart outcome not disclosed in the filing | On Track |
| Net debt/EBITDA within 2.5–3.0x policy range | management commentary in filings (open-ended) | 2.41x (own computation) | Met |
| FY27 capex ~Rs.20,000 cr (>60% India) | Q1 FY27 earnings call / FY27 plan | H1 purchase of capital assets Rs.6,859.65 cr (34% of plan) | On Track |
| "Production and deliveries are expected to normalise in the coming quarters" | Q1 FY27 call | India segment revenue +15.3% QoQ; India EBITDA +7.3% QoQ — in Rs. terms; volume tonnage not disclosed in the filing | Confirmed |
| "India continues to deliver industry-leading margins" | Q1 FY27 call | India margin 24.25%, above the group's every other operating segment | Confirmed |
| West Asia cost impact "expected to taper in the coming quarters" | Q1 FY27 call | Q2 quantum not disclosed in the filing | Too Early |
| UK+Netherlands FY27 EBITDA plan higher than FY26 | Q4 FY26 call | UK −Rs.719.25 cr (worse QoQ), NL Rs.790.29 cr (recovering, still −13.8% YoY) | Too Early |
| UK losses to approach zero through 1Q–2Q FY27 | Q4 FY26 call | Loss widened ~2.1x QoQ | Contradicted |
Key Numbers, Quarter by Quarter
| Metric | 2QFY26 | 3QFY26 | 4QFY26 | 1QFY27 | 2QFY27 |
|---|---|---|---|---|---|
| Consolidated operating EBITDA margin % (Reg 52) | 15.52 | 14.58 | 15.73 | 15.41 | 16.30 |
| NINL segment result Rs. cr | 260.17 | — | — | 498.48 | 318.32 |
| UK segment result Rs. cr | (764.92) | — | — | (340.72) | (719.25) |
| NL segment result Rs. cr | 916.40 | — | — | 39.12 | 790.29 |
Key Investment Insights
Key Positives
- Consolidated revenue grew 11.5% YoY to Rs.65,436.24 crore; India segment revenue grew 22.7% YoY to Rs.42,535.28 crore
- EBITDA of Rs.10,665.14 crore grew 17.1% YoY and 13.8% QoQ; margin of 16.30% is the best of the last five quarters
- India EBITDA of Rs.10,633.77 crore exceeded the guided target of beating Q1's Rs.9,908 crore despite margin compression to 24.25%
- Netherlands segment result rebounded to Rs.790.29 crore from Rs.39.12 crore in Q1
- Net worth (Reg 52) grew 9.6% YoY to Rs.1,00,337.40 crore; net debt/EBITDA of 2.41x remains within the 2.5–3.0x comfort band
- Standalone PAT grew 24.5% YoY to Rs.5,053.64 crore
Risk Factors
- UK segment loss widened to Rs.719.25 crore from Rs.340.72 crore in Q1, contradicting management's guidance that losses would approach zero
- Auditors issued a modified opinion (standalone, qualified) on unrecognised TSN impairment indicators of Rs.38,692.59 crore (PP&E Rs.33,272.58 crore plus goodwill Rs.5,420.01 crore)
- Normalized PAT declined 1.1% YoY; reported PAT growth of 18.2% is driven by a Rs.457.49 crore one-time TMILL fair-value gain
- Net debt rose Rs.11,101.76 crore in H1 to Rs.92,422.37 crore; net debt/EBITDA rose from 2.33x to 2.41x
- H1 CFO/EBITDA of 0.39x, driven by a Rs.6,415.84 crore inventory build and cash taxes nearly doubling to Rs.3,151.37 crore
- Standalone OCI of −Rs.10,323.22 crore from FVTOCI revaluation of the Rs.59,078.13 crore TSHW investment took standalone total comprehensive income to −Rs.5,269.58 crore
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Companies on this page
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.